Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
6,157,552
-
Share change
-
-901,178
-
Total reported value
-
$7,327,000
-
Price per share
-
$1.19
-
Number of holders
-
9
-
Value change
-
-$4,519,773
-
Number of buys
-
4
-
Number of sells
-
11
Institutional Holders of ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) as of Q2 2020
As of 30 Jun 2020,
ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,157,552 shares.
The largest 9 holders included
Canaan Partners X LLC, FRAZIER MANAGEMENT LLC, New Leaf Venture Partners, L.L.C., ARMISTICE CAPITAL, LLC, UBS OCONNOR LLC, TWO SIGMA INVESTMENTS, LP, McAdam, LLC, Bollard Group LLC, and Cypress Capital Management LLC (WY).
This page lists
9
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.